Oncology Biosimilars Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market

1.3 Market Segment by Type

1.3.1 China Oncology Biosimilars Market Size and Growth Rate of mAb from 2016 to 2027

1.3.2 China Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2016 to 2027

1.3.3 China Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2016 to 2027

1.3.4 China Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2016 to 2027

1.3.5 China Oncology Biosimilars Market Size and Growth Rate of Others from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

1.4.2 China Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027

1.4.3 China Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of Oncology Biosimilars by Major Types

3.4.1 Market Size and Growth Rate of mAb

3.4.2 Market Size and Growth Rate of Immunomodulators

3.4.3 Market Size and Growth Rate of Hematopoietic Agents

3.4.4 Market Size and Growth Rate of G-CSF

3.4.5 Market Size and Growth Rate of Others

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of Oncology Biosimilars by Major End-Users

4.4.1 Market Size and Growth Rate of Oncology Biosimilars in Retail Pharmacies

4.4.2 Market Size and Growth Rate of Oncology Biosimilars in Hospital Pharmacy

4.4.3 Market Size and Growth Rate of Oncology Biosimilars in Online Pharmacy

5.1 China Oncology Biosimilars Production Analysis by Regions

5.2 China Oncology Biosimilars Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China Oncology Biosimilars Landscape Analysis by Major Types

6.2 North China Oncology Biosimilars Landscape Analysis by Major End-Users

7.1 Central China Oncology Biosimilars Landscape Analysis by Major Types

7.2 Central China Oncology Biosimilars Landscape Analysis by Major End-Users

8.1 South China Oncology Biosimilars Landscape Analysis by Major Types

8.2 South China Oncology Biosimilars Landscape Analysis by Major End-Users

9.1 East China Oncology Biosimilars Landscape Analysis by Major Types

9.2 East China Oncology Biosimilars Landscape Analysis by Major End-Users

10.1 Northeast China Oncology Biosimilars Landscape Analysis by Major Types

10.2 Northeast China Oncology Biosimilars Landscape Analysis by Major End-Users

11.1 Southwest China Oncology Biosimilars Landscape Analysis by Major Types

11.2 Southwest China Oncology Biosimilars Landscape Analysis by Major End-Users

12.1 Northwest China Oncology Biosimilars Landscape Analysis by Major Types

12.2 Northwest China Oncology Biosimilars Landscape Analysis by Major End-Users

13.1 Teva Pharmaceutical Industries Ltd

13.2 BIOCAD

13.3 STADA Arzneimittel AG

13.4 Apotex

13.5 Celltrion

13.6 Dr Reddy’s Laboratories

13.7 Intas Pharmaceuticals

13.8 Biocon

13.9 Sandoz International

13.10 Pfizer

Figure Product Picture

Figure China Oncology Biosimilars Market Size and Growth Rate of mAb from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027

Figure China Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China Oncology Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of Oncology Biosimilars

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of Oncology Biosimilars by Different Types from 2016 to 2027

Table Consumption Share of Oncology Biosimilars by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of mAb

Figure Market Size and Growth Rate of Immunomodulators

Figure Market Size and Growth Rate of Hematopoietic Agents

Figure Market Size and Growth Rate of G-CSF

Figure Market Size and Growth Rate of Others

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of Oncology Biosimilars by Different End-Users from 2016 to 2027

Table Consumption Share of Oncology Biosimilars by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Retail Pharmacies

Figure Market Size and Growth Rate of Hospital Pharmacy

Figure Market Size and Growth Rate of Online Pharmacy

Table China Oncology Biosimilars Production by Regions

Table China Oncology Biosimilars Production Share by Regions

Figure China Oncology Biosimilars Production Share by Regions in 2016

Figure China Oncology Biosimilars Production Share by Regions in 2021

Figure China Oncology Biosimilars Production Share by Regions in 2027

Table China Oncology Biosimilars Consumption by Regions

Table China Oncology Biosimilars Consumption Share by Regions

Figure China Oncology Biosimilars Consumption Share by Regions in 2016

Figure China Oncology Biosimilars Consumption Share by Regions in 2021

Figure China Oncology Biosimilars Consumption Share by Regions in 2027

Table North China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table North China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure North China Oncology Biosimilars Consumption Share by Types in 2016

Figure North China Oncology Biosimilars Consumption Share by Types in 2021

Figure North China Oncology Biosimilars Consumption Share by Types in 2027

Table North China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table North China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure North China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure North China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure North China Oncology Biosimilars Consumption Share by End-Users in 2027

Table Central China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table Central China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure Central China Oncology Biosimilars Consumption Share by Types in 2016

Figure Central China Oncology Biosimilars Consumption Share by Types in 2021

Figure Central China Oncology Biosimilars Consumption Share by Types in 2027

Table Central China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table Central China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure Central China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure Central China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure Central China Oncology Biosimilars Consumption Share by End-Users in 2027

Table South China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table South China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure South China Oncology Biosimilars Consumption Share by Types in 2016

Figure South China Oncology Biosimilars Consumption Share by Types in 2021

Figure South China Oncology Biosimilars Consumption Share by Types in 2027

Table South China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table South China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure South China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure South China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure South China Oncology Biosimilars Consumption Share by End-Users in 2027

Table East China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table East China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure East China Oncology Biosimilars Consumption Share by Types in 2016

Figure East China Oncology Biosimilars Consumption Share by Types in 2021

Figure East China Oncology Biosimilars Consumption Share by Types in 2027

Table East China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table East China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure East China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure East China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure East China Oncology Biosimilars Consumption Share by End-Users in 2027

Table Northeast China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table Northeast China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure Northeast China Oncology Biosimilars Consumption Share by Types in 2016

Figure Northeast China Oncology Biosimilars Consumption Share by Types in 2021

Figure Northeast China Oncology Biosimilars Consumption Share by Types in 2027

Table Northeast China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table Northeast China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure Northeast China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure Northeast China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure Northeast China Oncology Biosimilars Consumption Share by End-Users in 2027

Table Southwest China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table Southwest China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure Southwest China Oncology Biosimilars Consumption Share by Types in 2016

Figure Southwest China Oncology Biosimilars Consumption Share by Types in 2021

Figure Southwest China Oncology Biosimilars Consumption Share by Types in 2027

Table Southwest China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table Southwest China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure Southwest China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure Southwest China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure Southwest China Oncology Biosimilars Consumption Share by End-Users in 2027

Table Northwest China Oncology Biosimilars Consumption by Types from 2016 to 2027

Table Northwest China Oncology Biosimilars Consumption Share by Types from 2016 to 2027

Figure Northwest China Oncology Biosimilars Consumption Share by Types in 2016

Figure Northwest China Oncology Biosimilars Consumption Share by Types in 2021

Figure Northwest China Oncology Biosimilars Consumption Share by Types in 2027

Table Northwest China Oncology Biosimilars Consumption by End-Users from 2016 to 2027

Table Northwest China Oncology Biosimilars Consumption Share by End-Users from 2016 to 2027

Figure Northwest China Oncology Biosimilars Consumption Share by End-Users in 2016

Figure Northwest China Oncology Biosimilars Consumption Share by End-Users in 2021

Figure Northwest China Oncology Biosimilars Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

Table Company Profile and Development Status of BIOCAD

Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD

Figure Sales and Growth Rate Analysis of BIOCAD

Figure Revenue and Market Share Analysis of BIOCAD

Table Product and Service Introduction of BIOCAD

Table Company Profile and Development Status of STADA Arzneimittel AG

Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG

Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG

Figure Revenue and Market Share Analysis of STADA Arzneimittel AG

Table Product and Service Introduction of STADA Arzneimittel AG

Table Company Profile and Development Status of Apotex

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

Figure Sales and Growth Rate Analysis of Apotex

Figure Revenue and Market Share Analysis of Apotex

Table Product and Service Introduction of Apotex

Table Company Profile and Development Status of Celltrion

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

Figure Sales and Growth Rate Analysis of Celltrion

Figure Revenue and Market Share Analysis of Celltrion

Table Product and Service Introduction of Celltrion

Table Company Profile and Development Status of Dr Reddy’s Laboratories

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s Laboratories

Figure Sales and Growth Rate Analysis of Dr Reddy’s Laboratories

Figure Revenue and Market Share Analysis of Dr Reddy’s Laboratories

Table Product and Service Introduction of Dr Reddy’s Laboratories

Table Company Profile and Development Status of Intas Pharmaceuticals

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas Pharmaceuticals

Figure Sales and Growth Rate Analysis of Intas Pharmaceuticals

Figure Revenue and Market Share Analysis of Intas Pharmaceuticals

Table Product and Service Introduction of Intas Pharmaceuticals

Table Company Profile and Development Status of Biocon

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

Figure Sales and Growth Rate Analysis of Biocon

Figure Revenue and Market Share Analysis of Biocon

Table Product and Service Introduction of Biocon

Table Company Profile and Development Status of Sandoz International

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International

Figure Sales and Growth Rate Analysis of Sandoz International

Figure Revenue and Market Share Analysis of Sandoz International

Table Product and Service Introduction of Sandoz International

Table Company Profile and Development Status of Pfizer

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

Figure Sales and Growth Rate Analysis of Pfizer

Figure Revenue and Market Share Analysis of Pfizer

Table Product and Service Introduction of Pfizer